CMP-CPS-001
Sponsors
Camp4 Therapeutics Corp., CAMP4 Therapeutics Corporation
Conditions
Healthy VolunteersUrea cycle disorders (UCD)
Phase 1
Study of CMP-CPS-001 in Healthy Volunteers
RecruitingNCT06247670
Start: 2024-02-05End: 2025-08-31Target: 96Updated: 2025-06-12
A Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Phase 1 Study of CMP-CPS-001 in Healthy Volunteers and Participants with Abnormal Heterozygous Ornithine Transcarbamylase (OTC) Genotype
Not yet recruitingCTIS2025-520882-37-00
Target: 12Updated: 2025-08-09